Sagus Sampath, M.D., is an assistant professor in the Department of Radiation Oncology. Dr. Sampath received his board certification in radiation oncology in 2011. While just beginning his academic career, he has already been first author on six peer-reviewed publications, has been invited to deliver five oral presentations at national meetings. “My passion is curing patients with aggressive cancers with sophisticated forms of radiation, while maintaining their high quality of life.” In his spare time, Dr. Sampath enjoys playing South Indian classical music on the violin, and he is a USTA level 4.0 tennis player. He is also fluent in Spanish.
Sampath S, Schultheiss TE, Hitchcock YJ, et al. Radiotherapy and extent of surgical resection in retroperitoneal soft-tissue sarcoma: multi-institutional analysis of 261 patients. J Surg Oncol 2010 Apr 1;101(5):345-50.
Sampath S, Schultheiss TE, Hitchcock YJ, et al. Pre-operative radiotherapy versus post-operative radiotherapy in soft-tissue sarcoma: multi-institutional analysis of 821 patients. Int J Radiat Oncol Biol Phys 2011 Oct 1;81(2):498-505.
Bauman JE, Austin M, Schmidt R, Kurland B, Vaezi A, Hayes DN, Mendez E, Parvathaneni U, Chai X, Sampath S, Martins RG. ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomized, phase II trial. Br J Cancer 2013 Oct 15;109(8):2096-105.
Sorra A, Schroeder TM, Liem B, Thompson W, and Sampath S. Predictive factors for radiation pneumonitis in patients receiving intensity-modulated radiation therapy for thoracic malignancy. J Nucl Med Radiat Ther 2013; 4:149.
Sun V, Kim J, Williams AC, Raz D, Sampath S, Ferrell B. Quality of Life and Symptoms Following Stereotactic Body Radiotherapy in Early Stage Lung Cancer Patients. Journal of Community and Supportive Oncology. 2014 Nov;12(11):407-414.
Sampath S, Hall MH, and Schultheiss TE. Definitive chemotherapy and radiotherapy in patients with stage II non-small cell lung cancer: a population-based outcomes study. Lung Cancer 2015 Oct;90(1):61-4.